+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Increased sensitivity of cholera toxin B treated K562 cells to natural killer cells



Increased sensitivity of cholera toxin B treated K562 cells to natural killer cells



Cellular Immunology 269(1): 1-4



Cholera toxin B-subunit (CTB) treatment of K562 erythroleukemia cells increased their sensitivity to be killed by NK-92 cells with more than 10%, compared to untreated cells. A similar treatment of non-T, non-B acute lymphoblastic REH leukemia cells, known to be unsensitive to NK cell mediated cytotoxicity, did not have any impact at all. Visualization of the cross-linked ganglioside(M1) (GM(1)) using fluorescent labeled CTB, indicated accumulation of the fluorescence to one cap and a few smaller patches in both type of cells. Additional cross-linking using anti-CTB antibodies further accentuated capping and increased lysis in the case of K562 cells. Blocking experiments performed with anti-MICA/B, ULBP-2 and/or CD59 antibodies could not inhibit the increased sensitivity mediated by CTB.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053806079

Download citation: RISBibTeXText

PMID: 21481337

DOI: 10.1016/j.cellimm.2011.03.019


Related references

Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells. International Journal of Cancer 65(5): 633-638, 1996

Increased sensitivity of gastric cancer cells to natural killer and lymphokine-activated killer cells by antisense suppression of N-acetylgalactosaminyltransferase. Journal of Immunology 159(6): 2645-2651, 1997

Sensitivity to acetyl tyrosine ethyl ester inhibition of cell mediated killing distinguishes freshly isolated natural killer cells from both in vitro activated natural killer cells and t killer cells. Federation Proceedings 41(3): ABSTRACT 851, 1982

Biology of natural killer cells: What is the relationship between natural killer cells and cancer? Will an increased number and/or function of natural killer cells result in lower cancer incidence?. Journal of Nutrition 135(12): 2910S, 2005

Papain pretreatment of natural killer target cells causes a decrease in sensitivity to lysis by natural killer cells or natural killer cytotoxic factors apparently due to destruction of natural killer cytotoxic factors binding sites. Federation Proceedings 44(3): 587, 1985

Interferon and prostaglandin e 2 act on the same subset of natural killer and pre natural killer cells to produce killer cells with an increased capacity for effector target lytic interactions re cycling. Federation Proceedings 40(3 Part 2): 1007, 1981

Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice. Annals of Hematology 90(8): 873-885, 2011

Increased susceptibility of periodate treated tumor cells to human but not to mouse or rat natural killer cells. Scandinavian Journal of Immunology 28(6): 697-704, 1988

Effect of cholera toxin and pertussis toxin on the growth of A431 cells: kinetics of cyclic AMP and inositol trisphosphate in toxin-treated cells. Hormone and Metabolic Research 27(3): 137-140, 1995

Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells. Cellular Immunology 118(2): 250-264, 1989

The incorporation of neoglycolipids into K562 cells: A model for the study of carbohydrate-dependent cytolysis of target cells by natural killer cells. Bioorganicheskaya Khimiya 24(3): 224-228, 1998

Incorporation of neoglycolipids into K562 cells. Model for the study of carbohydrate dependent lysis of target cells by natural killer cells. Bioorganicheskaia Khimiia 24(3): 224-228, 1998

Activation of human T-helper/inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK)-cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin. Bmc Complementary and Alternative Medicine 11: 59, 2011

A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562. Journal of Experimental Medicine 161(6): 1464-1482, 1985